More NewsRead More
Date Set for Arbitration Trial Between CEL-SCI and Clinical Research Organization inVentiv
January 06, 2015
CEL-SCI’s 2014 Patient Enrollment Increases Eight-Fold over 2013 in its Phase III Head and Neck Cancer Trial
January 05, 2015
CEL-SCI Reports Fiscal 2014 Financial Results and Clinical & Corporate Developments
December 23, 2014
CEL-SCI Receives Regulatory Clearance to Expand Its Phase III Head and Neck Cancer Trial into Romania
January 26, 2015
CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7 More Clinical Sites
December 08, 2014
CEL-SCI Quarterly Patient Enrollment in Its Head and Neck Cancer Phase III Trial Increases Eight Fold over Same Prior Year Period
December 02, 2014
CEL-SCI Enrolls 22 Patients During October in Its Phase III Immunotherapy Head and Neck Cancer Trial
November 03, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here